Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 3/20 | 0.35 |
| ▸ | CA2 | P00918 | 3/20 | 0.35 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.35 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | PPARA | Q07869 | 2/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5874546 | 0.83 | SLC22A1 (0.35) | SLC22A1TP53ENPP2 | |
| Betaine SCHEMBL23723254 | 0.82 | TSHR (0.50) | PPARAENPP2 | |
| Tetrabuthylammonium SCHEMBL243899 | 0.76 | SLC22A1 (0.67) | SLC22A1TP53CA1CA2SLC22A2 | |
| Tetrabuthylammonium SCHEMBL27990806 | 0.76 | SLC22A1 (0.67) | SLC22A1TP53CA1CA2SLC22A2 | |
| Tetrabuthylammonium SCHEMBL331036 | 0.74 | SLC22A1 (0.63) | SLC22A1TP53CA1CA2SLC22A2 | |
| Tetrabuthylammonium SCHEMBL20550034 | 0.74 | SLC22A1 (0.63) | SLC22A1TP53CA1CA2SLC22A2 | |
| Propane SCHEMBL11244315 | 0.74 | MEN1 (0.33) | DNM1 | |
| Tetrabuthylammonium SCHEMBL331004 | 0.74 | SLC22A1 (0.63) | SLC22A1TP53CA1CA2SLC22A2 | |
| Tributylmethylammonium SCHEMBL1627727 | 0.74 | TP53 (0.41) | SLC22A1TP53CA1CA2SLC22A2 | |
| Tetrabuthylammonium SCHEMBL9998667 | 0.74 | SLC22A1 (0.63) | SLC22A1TP53CA1CA2SLC22A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230339850-A1 | CANNABINOID SULFATE ESTERS, THEIR SALTS AND USES THEREOF | LONDON PHARMACEUTICALS AND RESEARCH CORPORATION (CA) | 2023-10-26 | — | — | US | claimed |
| EP-4100399-A1 | CANNABINOID SULFATE ESTERS, THEIR SALTS AND USES THEREOF | London Pharmaceuticals and Research Corporation (CA) | 2022-12-14 | — | — | EP | claimed |
| EP-4301762-A1 | SYNERGISTIC CANNABINOID ESTERS, THEIR SALTS AND USES THEREOF | London Pharmaceuticals and Research Corporation (CA) | 2024-01-10 | — | — | EP | disclosed |
| US-20230339850-A1 | CANNABINOID SULFATE ESTERS, THEIR SALTS AND USES THEREOF | LONDON PHARMACEUTICALS AND RESEARCH CORPORATION (CA) | 2023-10-26 | — | — | US | disclosed |
| EP-4100399-A1 | CANNABINOID SULFATE ESTERS, THEIR SALTS AND USES THEREOF | London Pharmaceuticals and Research Corporation (CA) | 2022-12-14 | — | — | EP | disclosed |
| WO-2022183292-A1 | SYNERGISTIC CANNABINOID ESTERS, THEIR SALTS AND USES THEREOF | LONDON PHARMACEUTICALS AND RESEARCH CORPORATION (CA) | 2022-09-09 | — | — | WO | disclosed |
| US-7128976-B2 | Composition for film formation, method of film formation, and silica-based film | JSR CORPORATION (JP) | 2006-10-31 | — | — | US | disclosed |
| US-20030091838-A1 | Composition for film formation, method of film formation, and silica-based film | JSR CORPORATION (JP) | 2003-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230339850-A1 | CANNABINOID SULFATE ESTERS, THEIR SALTS AND USES THEREOF | CNR2, CNR1, GPR18 | SLC22A1 829/4885TP53 2917/4885CA1 4528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.